HAF mediates the evasive resistance of anti-angiogenesis TKI through disrupting HIF-1α and HIF-2α balance in renal cell carcinoma.

Oncotarget · 2017 · PMC5564801 · PMID 28572533

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

an increasing trendno p-value reported

We observed a decreasing trend of HIF-1α protein levels and an increasing trend of HIF-2α and HAF protein levels over the duration of sunitinib treatment (Figure 4E ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.